ANPI Angiotech Pharmaceuticals - Common Shares (MM)

Angiotech Pharmaceuticals to participate in Deutsche Bank Conference VANCOUVER, April 26 /PRNewswire-FirstCall/ -- Angiotech Pharmaceuticals, Inc. (NASDAQ:ANPINASDAQ:TSX:NASDAQ:ANP), is scheduled to participate in the 30th Annual Deutsche Bank Healthcare Conference. Rui Avelar, Senior Vice President, Medical Affairs and Communications of Angiotech, will be making a 25-minute presentation at the conference on Tuesday, May 3rd, 2005 at 4:00 pm EST (1:00 pm PST). A live audio only webcast of Dr. Avelar's remarks will be available to all interested parties at Angiotech's website at http://www.angiotech.com/ in the Investor Relations section. To ensure a timely connection to the webcast, it is recommended that users register at least 15 minutes before the webcast begins. Vancouver-based Angiotech Pharmaceuticals, Inc. is a specialty pharmaceutical company pioneering the combination of pharmaceutical compounds with medical devices and biomaterials to both create novel solutions for challenging disease states and advance surgical outcomes. To find out more about Angiotech Pharmaceuticals, Inc. (NASDAQ:ANPINASDAQ:TSX:NASDAQ:ANP), please visit our website at http://www.angiotech.com/ . CONTACTS: Todd Young, Angiotech Pharmaceuticals (Analysts & Investors) (604) 221-7676 ext 6933 Rui Avelar, Angiotech Pharmaceuticals, Inc. (Analysts) (604) 221-7676 ext 6996 Eric Starkman, Starkman & Associates (Media) (212) 252-8545 ext 12 DATASOURCE: Angiotech Pharmaceuticals, Inc. CONTACT: Todd Young, Angiotech Pharmaceuticals (Analysts & Investors), (604) 221-7676 ext 6933; Rui Avelar, Angiotech Pharmaceuticals, Inc. (Analysts), (604) 221-7676 ext 6996; Eric Starkman, Starkman & Associates (Media), (212) 252-8545 ext 12

Copyright